Avantor [AVTR] vs Repligen [RGEN] Detailed Stock Comparison
Avantor
NYSE
Loading...
Repligen
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Avantor wins in 14 metrics, Repligen wins in 5 metrics, with 0 ties. Avantor appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Avantor | Repligen | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.14 | 511.11 | Avantor |
| Price-to-Book Ratio | 1.44 | 3.40 | Avantor |
| Debt-to-Equity Ratio | 67.49 | 33.28 | Repligen |
| PEG Ratio | 11.74 | 3.19 | Repligen |
| EV/EBITDA | 12.04 | 55.34 | Avantor |
| Profit Margin (TTM) | 10.31% | -2.05% | Avantor |
| Operating Margin (TTM) | 7.63% | 5.28% | Avantor |
| EBITDA Margin (TTM) | 7.63% | 5.28% | Avantor |
| Return on Equity | 11.73% | -0.68% | Avantor |
| Return on Assets (TTM) | 3.24% | 1.13% | Avantor |
| Free Cash Flow (TTM) | $692.00M | $142.49M | Avantor |
| 1-Year Return | -48.88% | -19.66% | Repligen |
| Price-to-Sales Ratio (TTM) | 1.36 | 10.42 | Avantor |
| Enterprise Value | $12.84B | $7.00B | Avantor |
| EV/Revenue Ratio | 1.93 | 10.38 | Avantor |
| Gross Profit Margin (TTM) | 32.92% | 49.98% | Repligen |
| Revenue per Share (TTM) | $10 | $12 | Repligen |
| Earnings per Share (Diluted) | $1.01 | $-0.25 | Avantor |
| Beta (Stock Volatility) | 0.96 | 1.05 | Avantor |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Avantor vs Repligen Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Avantor | -0.45% | 3.53% | -7.04% | 0.46% | -24.77% | -37.69% |
| Repligen | -2.83% | -2.27% | -0.39% | -1.04% | -24.90% | -15.23% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Avantor | -48.88% | -46.08% | -37.72% | -8.90% | -8.90% | -8.90% |
| Repligen | -19.66% | -42.35% | -16.60% | 266.34% | 3,508.93% | 3,025.26% |
Performance & Financial Health Analysis: Avantor vs Repligen
| Metric | AVTR | RGEN |
|---|---|---|
| Market Information | ||
| Market Cap | $9.05B | $7.02B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 9,301,350 | 697,970 |
| 90 Day Avg. Volume | 13,559,937 | 934,717 |
| Last Close | $13.21 | $121.26 |
| 52 Week Range | $10.82 - $27.83 | $102.97 - $182.52 |
| % from 52W High | -52.53% | -33.56% |
| All-Time High | $44.37 (Sep 20, 2021) | $327.32 (Sep 20, 2021) |
| % from All-Time High | -70.23% | -62.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.15% |
| Quarterly Earnings Growth | -0.30% | 1.60% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | -0.02% |
| Operating Margin (TTM) | 0.08% | 0.05% |
| Return on Equity (TTM) | 0.12% | -0.01% |
| Debt to Equity (MRQ) | 67.49 | 33.28 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.22 | $36.65 |
| Cash per Share (MRQ) | $0.66 | $12.60 |
| Operating Cash Flow (TTM) | $681.80M | $132.11M |
| Levered Free Cash Flow (TTM) | $688.84M | $155.35M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Avantor vs Repligen
| Metric | AVTR | RGEN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.14 | 511.11 |
| Forward P/E | 11.74 | 70.11 |
| PEG Ratio | 11.74 | 3.19 |
| Price to Sales (TTM) | 1.36 | 10.42 |
| Price to Book (MRQ) | 1.44 | 3.40 |
| Market Capitalization | ||
| Market Capitalization | $9.05B | $7.02B |
| Enterprise Value | $12.84B | $7.00B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.93 | 10.38 |
| Enterprise to EBITDA | 12.04 | 55.34 |
| Risk & Other Metrics | ||
| Beta | 0.96 | 1.05 |
| Book Value per Share (MRQ) | $9.22 | $36.65 |
Financial Statements Comparison: Avantor vs Repligen
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AVTR | RGEN |
|---|---|---|
| Revenue/Sales | $1.58B | $182.37M |
| Cost of Goods Sold | $1.05B | $91.22M |
| Gross Profit | $534.90M | $91.14M |
| Research & Development | N/A | $13.96M |
| Operating Income (EBIT) | $147.40M | $5.96M |
| EBITDA | $230.80M | $33.81M |
| Pre-Tax Income | $85.70M | $18.22M |
| Income Tax | $21.20M | $3.35M |
| Net Income (Profit) | $64.50M | $14.87M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AVTR | RGEN |
|---|---|---|
| Cash & Equivalents | $315.70M | $697.23M |
| Total Current Assets | $2.28B | $1.03B |
| Total Current Liabilities | $2.03B | $152.00M |
| Long-Term Debt | $3.28B | $668.54M |
| Total Shareholders Equity | $6.10B | $1.99B |
| Retained Earnings | $2.27B | $413.18M |
| Property, Plant & Equipment | N/A | $265.24M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AVTR | RGEN |
|---|---|---|
| Operating Cash Flow | $86.60M | $14.16M |
| Capital Expenditures | N/A | $-3.52M |
| Free Cash Flow | $81.30M | $10.58M |
| Debt Repayment | $-31.30M | N/A |
| Common Stock Repurchase | $-4.90M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AVTR | RGEN |
|---|---|---|
| Shares Short | 40.70M | 3.64M |
| Short Ratio | 3.51 | 3.98 |
| Short % of Float | 0.08% | 0.09% |
| Average Daily Volume (10 Day) | 9,301,350 | 697,970 |
| Average Daily Volume (90 Day) | 13,559,937 | 934,717 |
| Shares Outstanding | 680.80M | 56.09M |
| Float Shares | 664.01M | 52.66M |
| % Held by Insiders | 0.01% | 0.06% |
| % Held by Institutions | 1.06% | 1.05% |
Dividend Analysis & Yield Comparison: Avantor vs Repligen
| Metric | AVTR | RGEN |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |